ovarian cancer
Johnson & Johnson hit with $72m damages in talc-cancer case
A jury in the US state of Missouri has ordered Johnson & Johnson (J&J) to pay $72m (£51m) to the family of a woman who claimed her death was linked to use of the company's Baby Powder talc.
Study quantifies faulty gene's role in ovary cancer risk
Women who carry an inherited fault in the BRIP1 gene are three times more likely to develop ovarian cancer than those without it, researchers say.
Ovarian cancer: Screening may cut deaths by a fifth
Doctors say there is now "encouraging" evidence that an annual blood test may cut ovarian cancer deaths by a fifth.
Blood test 'boost' in ovarian cancer fight
Regular blood tests can detect 86% of ovarian cancers before the point at which women normally would be diagnosed, according to a trial that could lead to national screening.
Modifying human eggs to remove filial disease
American scientists are attempting to modify the DNA of human egg cells using a new gene-editing technique that could eliminate inherited diseases from subsequent generations of affected families
Johnson & Johnson hit with $72m damages in talc-cancer case
A jury in the US state of Missouri has ordered Johnson & Johnson (J&J) to pay $72m (£51m) to the family of a woman who claimed her death was linked to use of the company's Baby Powder talc.
Study quantifies faulty gene's role in ovary cancer risk
Women who carry an inherited fault in the BRIP1 gene are three times more likely to develop ovarian cancer than those without it, researchers say.
Ovarian cancer: Screening may cut deaths by a fifth
Doctors say there is now "encouraging" evidence that an annual blood test may cut ovarian cancer deaths by a fifth.
Blood test 'boost' in ovarian cancer fight
Regular blood tests can detect 86% of ovarian cancers before the point at which women normally would be diagnosed, according to a trial that could lead to national screening.
Modifying human eggs to remove filial disease
American scientists are attempting to modify the DNA of human egg cells using a new gene-editing technique that could eliminate inherited diseases from subsequent generations of affected families
